文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center.

作者信息

Castelli Giovana De Marchi, Friederich Frederico, Wiemann Anasthácia Ferreira, Santos Giovana Dos, Pitrez Paulo Márcio

机构信息

. Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA - Porto Alegre (RS) Brasil.

. Pontifícia Universidade Católica do Rio Grande do Sul - PUCRS - Porto Alegre (RS) Brasil.

出版信息

J Bras Pneumol. 2024 May 27;50(2):e20230405. doi: 10.36416/1806-3756/e20230405.

DOI:10.36416/1806-3756/e20230405
PMID:38808829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11185146/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f10/11185146/558ceb50216c/1806-3756-jbpneu-50-02-e20230405-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f10/11185146/558ceb50216c/1806-3756-jbpneu-50-02-e20230405-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f10/11185146/558ceb50216c/1806-3756-jbpneu-50-02-e20230405-gf1.jpg

相似文献

[1]
Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center.

J Bras Pneumol. 2024-5-27

[2]
Clinical remission with biologic therapies in severe asthma: a matter of definition.

Eur Respir J. 2024-6

[3]
Effect of inhaled corticosteroid use on weight (BMI) in pediatric patients with moderate-severe asthma.

J Asthma. 2019-3

[4]
Impact of asthma severity on long-term asthma control.

J Asthma. 2021-6

[5]
Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control.

Respir Med. 2014-4

[6]
How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.

Chest. 2024-5

[7]
Current practices and newer agents for the management of pediatric asthma.

JAAPA. 2000-6

[8]
Uncontrolled asthma and its risk factors in Chinese children: A cross-sectional observational study.

J Asthma. 2016-9

[9]
Clinical and economic burden of severe asthma among US patients treated with biologic therapies.

Ann Allergy Asthma Immunol. 2021-9

[10]
Ambulatory management of pediatric asthma.

Respir Care Clin N Am. 2000-3

引用本文的文献

[1]
What is the influence of exacerbations on pulmonary function in pediatric and adolescent patients with severe asthma despite controller therapies?

Clin Transl Allergy. 2025-4

本文引用的文献

[1]
Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?

Int Arch Allergy Immunol. 2022

[2]
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma.

Pediatr Allergy Immunol. 2021-7

[3]
An expert consensus framework for asthma remission as a treatment goal.

J Allergy Clin Immunol. 2019-12-19

[4]
Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study.

Allergy. 2019-5

[5]
Impact of omalizumab in children from a middle-income country with severe therapy-resistant asthma: A real-life study.

Pediatr Pulmonol. 2017-11

[6]
Omalizumab for asthma in adults and children.

Cochrane Database Syst Rev. 2014-1-13

[7]
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Eur Respir J. 2013-12-12

[8]
Classification of asthma severity in children: the contribution of pulmonary function testing.

Arch Pediatr Adolesc Med. 2006-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索